|
WO2021061853A1
|
|
Cbl inhibitors and compositions for use in adoptive cell therapy
|
|
WO2021021761A1
|
|
Urea, amide, and substituted heteroaryl compounds for cbl-b inhibition
|
|
WO2020264398A1
|
|
Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereof
|
|
WO2020236654A1
|
|
Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof
|
|
US2020323904A1
|
|
3-substituted piperidine compounds for cbl-b inhibition, and use of a cbl-b inhibitor in combination with a cancer vaccine and/or oncolytic virus
|
|
WO2020167518A1
|
|
Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
|
|
WO2020081450A1
|
|
Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
|
|
WO2019148005A1
|
|
Inhibitors of cbl-b and methods of use thereof
|
